Patients with suspected Kawasaki disease, either complete or incomplete, should be admitted to an appropriate pediatric inpatient facility. Treatment for Kawasaki disease involves, at a minimum, an infusion of IVIG, which is typically given over a period of hours. Side effects of this medication may include fever, headache, urticaria, nausea, vomiting, and blood pressure instability. Although uncommon, anaphylaxis, Stevens-Johnson syndrome, and nephrotoxicity have been reported, so it is in the best interest of the patient to be admitted for monitoring during treatment.
To continue reading, please log in or purchase access.